<DOC>
	<DOCNO>NCT02176356</DOCNO>
	<brief_summary>A study evaluate patient satisfaction , aesthetic psychological impact combine treatment BOTOX® Cosmetic ( onabotulinumtoxinA ) , JUVÉDERM® ULTRA XC , JUVÉDERM® ULTRA PLUS XC , JUVÉDERM® VOLUMA® XC , LATISSE® ( bimatoprost ophthalmic solution ) .</brief_summary>
	<brief_title>Patient Satisfaction Study Combined Facial Treatment With BOTOX® Cosmetic , JUVÉDERM® LATISSE® ( HARMONY Study )</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Qualified receive treatment BOTOX® Cosmetic , facial filler ( JUVÉDERM® ULTRA XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC ) LATISSE® treatment Naïve botulinum toxin therapy serotype indication Naïve prescription eyelash growth product type Naïve dermal filler treatment face neck Undergone facial plastic surgery , tissue grafting , tissue augmentation facial dermal filler injection Had laser , photomodulation , intense pulse light , radio frequency , dermabrasion chemical peel face neck Have receive skin resurfacing ( laser , photomodulation , intense pulse light , radio frequency , dermabrasion , chemical peel , nonablative procedure ) face neck within 3 month Systemic retinoid therapy within 1 year prior study enrollment Presence inflammation propose injection site ( ) Profound atrophy/excessive weakness muscle target area injection Known immunization hypersensitivity botulinum toxin serotype Undergone oral surgery dental procedure within 30 day No visible eyelash Use permanent eyeliner , eyelash implant , semipermanent eyelash tint , dye extension Use prescription eyelash growth product Unwilling unable remove contact lenses prior study medication application even keep lens 30 minute Diagnosis myasthenia gravis , EatonLambert Syndrome , amyotrophic lateral sclerosis , disease might interfere neuromuscular function .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>